[go: up one dir, main page]

FI952203L - Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi - Google Patents

Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi Download PDF

Info

Publication number
FI952203L
FI952203L FI952203A FI952203A FI952203L FI 952203 L FI952203 L FI 952203L FI 952203 A FI952203 A FI 952203A FI 952203 A FI952203 A FI 952203A FI 952203 L FI952203 L FI 952203L
Authority
FI
Finland
Prior art keywords
compounds
preparation
treating diseases
cyclohexane derivatives
cyclohexane
Prior art date
Application number
FI952203A
Other languages
English (en)
Swedish (sv)
Other versions
FI110097B (fi
FI952203A0 (fi
Inventor
Horst Hemmerle
Gerrit Schubert
Hans-Joerg Burger
Andreas Herling
Suad Efendic
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI952203A0 publication Critical patent/FI952203A0/fi
Publication of FI952203L publication Critical patent/FI952203L/fi
Application granted granted Critical
Publication of FI110097B publication Critical patent/FI110097B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI952203A 1994-05-10 1995-05-08 5-(3-imidatso[4,5-b]pyridin-1-yyli-3-fenyyli-akryloyylioksi)-sykloheksaanikarboksyylihappojohdannaiset, niiden käyttö ja yhdisteitä sisältävät lääkeaineet FI110097B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4416433 1994-05-10
DE4416433A DE4416433A1 (de) 1994-05-10 1994-05-10 Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten

Publications (3)

Publication Number Publication Date
FI952203A0 FI952203A0 (fi) 1995-05-08
FI952203L true FI952203L (fi) 1995-11-11
FI110097B FI110097B (fi) 2002-11-29

Family

ID=6517746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952203A FI110097B (fi) 1994-05-10 1995-05-08 5-(3-imidatso[4,5-b]pyridin-1-yyli-3-fenyyli-akryloyylioksi)-sykloheksaanikarboksyylihappojohdannaiset, niiden käyttö ja yhdisteitä sisältävät lääkeaineet

Country Status (22)

Country Link
US (1) US5739147A (fi)
EP (1) EP0682024B1 (fi)
JP (1) JP3790564B2 (fi)
KR (1) KR100355690B1 (fi)
CN (1) CN1043643C (fi)
AT (1) ATE187454T1 (fi)
AU (1) AU683148B2 (fi)
CA (1) CA2149007C (fi)
CZ (1) CZ288443B6 (fi)
DE (2) DE4416433A1 (fi)
DK (1) DK0682024T3 (fi)
ES (1) ES2141276T3 (fi)
FI (1) FI110097B (fi)
GR (1) GR3032519T3 (fi)
HU (1) HU220865B1 (fi)
NO (1) NO304314B1 (fi)
NZ (1) NZ272082A (fi)
PL (1) PL180074B1 (fi)
RU (1) RU2140416C1 (fi)
TW (1) TW421648B (fi)
UA (1) UA41340C2 (fi)
ZA (1) ZA953726B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
EP1741447B1 (en) 2000-01-21 2013-09-18 Novartis AG Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents
US20040143015A1 (en) * 2001-03-12 2004-07-22 Villhauer Edwin Bernard Combination of organic compounds
FR2852957B1 (fr) * 2003-03-31 2005-06-10 Sod Conseils Rech Applic Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
EP1931350B2 (en) 2005-09-14 2021-08-04 Takeda Pharmaceutical Company Limited Administration of dipeptidyl peptidase inhibitors
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
CN102834393B (zh) 2010-02-03 2015-07-22 武田药品工业株式会社 细胞凋亡信号调节激酶1抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
TW255880B (fi) * 1992-09-09 1995-09-01 Hoechst Ag
DE4408082A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE4413402A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Herstellung von Zwischenprodukten für die Synthese von Glucose-6-Phosphatase-Inhibitoren sowie neue Zwischenprodukte

Also Published As

Publication number Publication date
EP0682024B1 (de) 1999-12-08
ZA953726B (en) 1996-01-11
HK1011989A1 (en) 1999-07-23
CZ119595A3 (en) 1995-12-13
CN1043643C (zh) 1999-06-16
ATE187454T1 (de) 1999-12-15
HU220865B1 (en) 2002-06-29
AU1792395A (en) 1995-11-16
CZ288443B6 (en) 2001-06-13
DE4416433A1 (de) 1995-11-16
CA2149007A1 (en) 1995-11-11
DK0682024T3 (da) 2000-05-22
KR100355690B1 (ko) 2002-12-26
GR3032519T3 (en) 2000-05-31
FI110097B (fi) 2002-11-29
US5739147A (en) 1998-04-14
PL180074B1 (pl) 2000-12-29
NZ272082A (en) 1996-09-25
JP3790564B2 (ja) 2006-06-28
KR950032191A (ko) 1995-12-20
FI952203A0 (fi) 1995-05-08
AU683148B2 (en) 1997-10-30
NO304314B1 (no) 1998-11-30
CA2149007C (en) 2005-07-26
NO951820D0 (no) 1995-05-09
RU95107147A (ru) 1997-03-20
HUT71797A (en) 1996-02-28
ES2141276T3 (es) 2000-03-16
DE59507361D1 (de) 2000-01-13
JPH07330767A (ja) 1995-12-19
NO951820L (no) 1995-11-13
PL308521A1 (en) 1995-11-13
RU2140416C1 (ru) 1999-10-27
UA41340C2 (uk) 2001-09-17
TW421648B (en) 2001-02-11
CN1118782A (zh) 1996-03-20
EP0682024A1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
FI963696A7 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
FI962954A7 (fi) Substituoidut 3-arylideeni-7-atsaoksindoliyhdisteet ja menetelmä niiden valmistamiseksi
EE9700031A (et) Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9700153A (et) Heterotsükliga kondenseerunud püridiinid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9600019A (et) 2,8-diasendatud kinasolinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE03482B1 (et) Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
EE9700043A (et) Asendatud oksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
FI903215A7 (fi) Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
FI964102L (fi) Menetelmä fenolin ja fenolijohdannaisten valmistamiseksi
EE9700019A (et) 2-okso- ja 2-tio1,2-dihüdrokinolinüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
FI971268A7 (fi) Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi
BR9502471A (pt) Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
IT8009551A0 (it) E-5-(2-alogenovinil-)-2'deossicitidine, loro metodo di preparazione e loro impiego per il trattamentodi malattie da virus
EE03878B1 (et) 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete ühendite valmistamiseks
FI971527A7 (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
EE9600023A (et) Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
FI952203L (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi

Legal Events

Date Code Title Description
MA Patent expired